Mesenchymal stromal cells contribute to quiescence of therapy ‐resistant leukemic cells in acute myeloid leukemia

ConclusionsOur data suggest that hMSC contribute to quiescence and therapy resistance of persistent AML cells.

Source: European Journal of Haematology - September 13, 2017 Category: Hematology Authors: Wenwen Wang, Tilmann Bochtler, Patrick Wuchter, Linda Manta, Haiju He, Volker Eckstein, Anthony D. Ho, Christoph Lutz Tags: ORIGINAL ARTICLE Source Type: research